Journal of Pediatric Health Care
Volume 20, Issue 4 , Pages 229-237 , July 2006

Update on Adolescent Immunization: Review of Pertussis and the Efficacy, Safety, and Clinical Use of Vaccines That Contain Tetanus-Diphtheria-Acellular Pertussis

  • Thad R. Wilson, PhD, APRN, BC

      Affiliations

    • Corresponding Author InformationReprint requests: Thad Wilson, PhD, APRN, BC, University of Missouri–Kansas City School of Nursing, 2220 Holmes, HSB 101, Kansas City, MO 64108

References 

  1. ADACEL. (2005). Prescribing information. Aventis Pasteur Limited, Toronto, Ontario, Canada.
  2. Advisory Committee on Immunization Practices. (June 30, 2005). ACIP recommends adolescent vaccination for tetanus, diphtheria and pertussis vaccine [National Immunization Program press release]. Retrieved July 25, 2005 from http://www.cdc.gov/nip/pr/pr_tdap_jun2005.htm
  3. American Medical Association . AMA guidelines for adolescent preventive services (GAPS) (Recommendations and rationale) . Chicago: Department of Adolescent Health, American Medical Association; 1997;
  4. Aoyama T , Arracima M , Nishimura K , Saito Y . Outbreak of pertussis in highly immunized adolescents and its secondary spread to their families . Acta Paediatrica, Japonica . 1995;37:321–324
  5. BOOSTRIX. (2005). Prescribing information. GlaxoSmithKline Biologicals, Rixensart, Belgium.
  6. Broder, K., & Mijalski, C. (2005, March). A big whoop: Current challenges and new directions for pertussis in the United States. Paper presented at the 39th National Immunization Conference, Washington, DC.
  7. Caro, J. J., Getsios, D., El-Hadi, W., Payne, K., O’Brien, J.A., & Tan, T., for the Global Pertussis Initiative. (2003, September). The economic impact of vaccinating adolescents for pertussis (poster G-1644). Poster presented at the 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL.
  8. Cattaneo LA , Reed GW , Haase DH , Wills MJ , Edwards KM . The seroepidemiology of Bordetella pertussis infections (A study of persons ages 1-65 years) . Journal of Infectious Diseases . 1996;173:1256–1259
  9. Centers for Disease Control and Prevention . Notifiable diseases/deaths in selected cities weekly information . MMWR Morbidity and Mortality Weekly Report . 2005;53:1213–1221
  10. Centers for Disease Control and Prevention . Pertussis . In:  Atkinson W ,  Hamborsky J ,  Wolfe C editor. Epidemiology and prevention of vaccine-preventable diseases . Washington, DC: Public Health Foundation; 2005;p. 75–88
  11. Centers for Disease Control and Prevention . Summary of notifiable diseases—United States, 2003 . MMWR Morbidity and Mortality Weekly Report . 2005;52:1–85
  12. Centers for Disease Control and Prevention . Summary of notifiable diseases—United States, 2002 . MMWR Morbidity and Mortality Weekly Report . 2004;51:1–84
  13. Centers for Disease Control and Prevention . Vaccination coverage among children entering school—United States, 2003-2004 school year . MMWR Morbidity and Mortality Weekly Report . 2004;53:1041–1044
  14. Centers for Disease Control and Prevention . Youth risk behavior surveillance—United States, 2003 . MMWR Morbidity and Mortality Weekly Report . 2004;53(SS-2):1–100
  15. Centers for Disease Control and Prevention . General recommendations on immunization (Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP)) . MMWR Morbidity and Mortality Weekly Report . 2002;51:1–36
  16. Centers for Disease Control and Prevention . Pertussis—United States, 1997-2000 . MMWR Morbidity and Mortality Weekly Report . 2002;51:73–76
  17. Centers for Disease Control and Prevention . Summary of notifiable diseases—United States, 1999 . MMWR Morbidity and Mortality Weekly Report . 2001;48:1–104
  18. Centers for Disease Control and Prevention . Case definitions for infectious conditions under public health surveillance . MMWR Morbidity and Mortality Weekly Report . 1997;46:1–55
  19. Centers for Disease Control and Prevention . Pertussis outbreak—Vermont, 1996 . MMWR Morbidity and Mortality Weekly Report . 1997;46:822–826
  20. Centers for Disease Control and Prevention . Status report on the Childhood Immunization Initiative (National, state, and urban area vaccination coverage levels among children aged 19-35 months—United States, 1996) . MMWR Morbidity and Mortality Weekly Report . 1997;46:657–664
  21. Centers for Disease Control and Prevention . Summary of notifiable diseases—United States, 1996 . MMWR Morbidity and Mortality Weekly Report . 1997;45:1–87
  22. Centers for Disease Control and Prevention . Summary of notifiable diseases—United States, 1993 . MMWR Morbidity and Mortality Weekly Report . 1994;42:1–73
  23. Cherry JD . Epidemiological, clinical, and laboratory aspects of pertussis in adults . Clinical Infectious Disease . 1999;28:S112–S117
  24. Daum, R. S., Marshall, G., Walter, E., & Bologa, M. (2004). Immunogenicity of tetanus-diphtheria-acellular pertussis (TdaP) vaccine in adolescents. Abstract presented at the American Academy of Pediatrics National Conference and Exhibition, San Francisco, CA.
  25. Davis JP . Clinical and economic effects of pertussis outbreaks . Pediatric Infectious Disease Journal . 2005;24:S109–S116
  26. De Serres G , Shadmani R , Duval B , Boulianne N , Déry P , Fradet MD , et al.   Morbidity of pertussis in adolescents and adults . Journal of Infectious Disease . 2000;182:174–179
  27. Deen JL , Mink CM , Cherry JD , Christenson PD , Pineda EF , Lewis K , et al.   Household contact study of Bordetella pertussis infections . Clinical Infectious Disease . 1995;21:1211–1219
  28. Dey AN , Bloom B . Summary health statistics for the US children (National Health Interview Survey, 2003) . Vital Health Statistics . 2005;10:1–78
  29. Dworkin MS . Adults are whooping, but are internists listening? . Annals Internal Medicine . 2005;142:832–835
  30. Forsyth KD , Campins-Marti M , Caro J , Cherry JD , Greenberg D , Guiso N , et al.   New pertussis vaccination strategies beyond infancy (Recommendations by the Global Pertussis Initiative) . Clinical Infectious Disease . 2004;39:1802–1809
  31. Foundation for Accountability The Robert Wood Johnson Foundation . A portrait of adolescents in America, 2001 . Portland, OR: The Foundation for Accountability; 2001;
  32. Friedland L , Descamps D  GlaxoSmithKline Boostrix™ Vaccine Study Group . Reduced antigen content tetanus-diphtheria-acellular pertussis (Tdap) vaccine is immunogenic and safe in adolescents (Results of a randomized trial) . 2004; Abstract presented at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC.
  33. Güris D , Strebel PM , Bardenheier B , Brennan M , Tachdjian R , Finch E , et al.   Changing epidemiology of pertussis in the United States (Increasing reported incidence among adolescents and adults, 1990-1996) . Clinical Infectious Disease . 1999;28:1230–1237
  34. Halperin SA . Canadian experience with implementation of an acellular pertussis vaccine booster-dose program in adolescents (Implications for the United States) . Pediatric Infectious Disease Journal . 2005;24:S141–S146
  35. Halperin SA , Smith B , Russell M , Scheifele D , Mills E , Hasselback P , et al.   Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults . Pediatric Infectious Disease Journal . 2000;19:276–283
  36. Hewlett EL , Edwards KM . Pertussis—not just for kids . New England Journal of Medicine . 2005;352:1215–1222
  37. Institute of Medicine . Vaccines for the 21st century (A tool for decision-making) . Washington, DC: National Academy Press; 2000;
  38. Jenkinson D . Duration of effectiveness of pertussis vaccine (Evidence from a 10 year community study) . British Medical Journal . 1988;296:612–614
  39. Kenyon TA , Izurieta H , Shulman ST , Rosenfeld E , Miller M , Daum R , et al.   Large outbreak of pertussis among young children in Chicago, 1993 (Investigation of potential contributing factors and estimation of vaccine effectiveness) . Pediatric Infectious Disease Journal . 1996;15:655–661
  40. Khetsuriani N , Bisgard K , Prevots DR , Brennan M , Wharton M , Pandya S , et al.   Pertussis outbreak in an elementary school with high vaccination coverage . Pediatric Infectious Disease Journal . 2001;20:1108–1112
  41. Le T , Cherry JD , Chang SJ , Knoll MD , Lee ML , Barenkamp S , et al.   Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine (The APERT study) . Journal of Infectious Disease . 2004;190:535–544
  42. Lee GM , Lett S , Schauer S , LeBaron C , Murphy TV , Rusinak D , et al.   Societal costs and morbidity of pertussis in adolescents and adults . Clinical Infectious Disease . 2004;39:1572–1580
  43. Minh NNT , He Q , Ramalho A , Kaufhold A , Viljanen MK , Arvilommi H , et al.   Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents . Pediatrics . 1999;104:e70–e76
  44. National Committee for Quality Assurance . Adolescent immunization status. State of health care quality report . 2003; Retrieved April 12, 2005, from http://www.ncqa.org/sohc2003/adolescent_immunization_status.htm.
  45. Ozer EM , Park MJ , Paul T , Brindis CD , Irwin CE . America’s adolescents (Are they healthy?) . San Francisco, CA: National Adolescent Health Information Center; 2003;
  46. Pichichero ME , Treanor J . Economic impact of pertussis . Archives of Pediatrics & Adolescent Medicine . 1997;151:35–40
  47. Pichichero, M. E., Blatter, M. M., Kennedy, W. A., Hendrick, J., Descamps, D., & Friedland, L. R. (2006). Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents. Pediatric Infectious Disease Journal, 117, in press.
  48. Pichichero ME , Rennels MB , Edwards KM , Blatter MM , Marshall GS , Bologa M , et al.   Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults . JAMA . 2005;293:3003–3011
  49. Purdy KW , Hay JW , Botteman MF , Ward JI . Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults (A cost-benefit analysis) . Clinical Infectious Disease . 2004;39:20–28
  50. Rickert D , Deladisma A , Yusuf H , Averhoff F , Brink E , Shih S . Adolescent immunizations (Are we ready for a new wave?) . American Journal Preventive Medicine . 2004;26:22–28
  51. Schaffer SJ , Humiston SG , Shone LP , Averhoff FM , Szilagyi PG . Adolescent immunization practices (A national survey of US physicians) . Archives Pediatrics Adolescent Medicine . 2001;155:566–571
  52. Sotir, M. J., Cappazzo, D. L., Schmidt, C. E., Warshauer, D. M., Zastrow, J. A., Monson, T. A., et al. (2005, March). A resource and labor intensive county-wide outbreak of pertussis, Wisconsin, 2003: High impact on the adolescent population. Abstract presented at the 39th National Immunization Conference, Washington, DC.
  53. Strebel P , Nordin J , Edwards K , Hunt J , Besser J , Burns S , et al.   Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996 . Journal of Infectious Disease . 2001;183:1353–1359
  54. US Census Bureau . Census 2000 briefs: Hispanic or Latino origin population; white alone not-Hispanic or Latino origin population; and population other than white alone not-Hispanic or Latino origin, by age and sex for the United States: 2000 . 2000; Retrieved April 12, 2005, from http://www.census.gov/population/cen2000/phc-t08/tab08.pdf.
  55. US Department of Health and Human Services . Healthy People 2010 (Understanding and improving health) . 2nd ed.. Washington, DC: US Government Printing Office; 2000;
  56. Van Damme P , Burgess M . Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults . Vaccine . 2004;22:305–308
  57. Van der Wielen M , Van Damme P , Joossens E , Francois G , Meurice F , Ramalho A . A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults . Vaccine . 2000;18:2075–2082
  58. Wirsing von König CH , Postels-Multani S , Bock HL , Schmitt HJ . Pertussis in adults (Frequency of transmission after household exposure) . Lancet . 1995;346:1326–1329
  59. Yaari E , Yafe-Zimerman Y , Schwartz SB , Slater PE , Shvartzman P , Andoren N , et al.   Clinical manifestations of Bordetella pertussis infection in immunized children and young adults . Chest . 1999;115:1254–1258
  60. Yih WK , Lett SM , des Vignes FN , Garrison KM , Sipe PL , Marchant CD . The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998 . Journal of Infectious Disease . 2000;182:1409–1416
  61. Ziv A , Boulet JR , Slap GB . Utilization of physician offices by adolescents in the United States . Pediatrics . 1999;104:35–42

PII: S0891-5245(05)00501-8

doi: 10.1016/j.pedhc.2005.12.011

Journal of Pediatric Health Care
Volume 20, Issue 4 , Pages 229-237 , July 2006

Article Tools

* Image Usage & Resolution